Cumberland Pharmaceuticals Inc (CPIX.OQ)

CPIX.OQ

About

Cumberland Pharmaceuticals Inc. (Cumberland) is specialty pharmaceutical company focused on the acquisition, development and commercialization of branded prescription products. Cumberland is focused on acquiring rights to, developing and commercializing prescription products for the hospital care and gastroenterology markets.... (more)

Buy/Sell

» Analyst Consensus

Overall

Beta:	1.46
Market Cap (Mil.):	$89.28
Shares Outstanding (Mil.):	18.45
Dividend:	--
Yield (%):	--

Financials

	CPIX.OQ	Industry	Sector
P/E (TTM):	15.12	35.66	35.83
EPS (TTM):	0.32	--	--
ROI:	6.98	19.36	18.72
ROE:	7.51	20.07	19.54

Latest News about CPIX.OQ

» More CPIX.OQ News

Competitors

	Price	Change
Takeda Pharmaceutical Company Limited (4502.T)	¥4,940	-10.00
Hospira, Inc. (HSP.N)	$36.03	+0.29
Sucampo Pharmaceuticals, Inc. (SCMP.OQ)	$9.50	+0.04
Johnson & Johnson (JNJ.N)	$88.01	-0.08
Novartis AG (NOVN.VX)	CHF71.50	-0.25
Pfizer Inc. (PFE.N)	$28.70	-0.26
BASF SE (BASFn.DE)	€74.47	+0.53

Earnings vs. Estimates

Analyst Research Reports

Report Title	Price
Thomson Reuters Stock Report - CUMBERLAND PHARMACEUTICALS INCORPORATION (CPIX-O) Provider: Thomson Reuters Stock Report	$25.00 Buy
Wright Investors Service Comprehensive Report for Cumberland Pharmaceuticals Incorporation Provider: Wright Reports	$460.00 Buy
CUMBERLAND PHARMACEUTICALS LTD (CPIX) 12-months forecast Provider: Pechala's Reports	$15.00 Buy
Cumberland Pharmaceuticals Inc: Business description, financial summary, 3yr and interim financials, key statistics/ratios and historical ratio analysis. Provider: Reuters Investment Profile	$20.00 Buy
ValuEngine Detailed Valuation Report for CPIX Provider: ValuEngine, Inc.	$127.00 Buy

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

» More Analyst Research

Related Topics:

Edition:

U.S.
- Arabic
- Argentina
- Brazil
- Canada
- China
- France
- Germany
- India
- Italy
- Japan
- Latin America
- Mexico
- Russia
- Spain
- United Kingdom

Back to top

Reuters.com

Legal

Support & Contact

Connect with Reuters

About

Our Flagship financial information platform incorporating Reuters Insider

An ultra-low latency infrastructure for electronic trading and data distribution

A connected approach to governance, risk and compliance

Our next generation legal research platform

Our global tax workstation

Thomson Reuters is the world's largest international multimedia news agency, providing investing news, world news, business news, technology news, headline news, small business news, news alerts, personal finance, stock market, and mutual funds information available on Reuters.com, video, mobile, and interactive television platforms. Thomson Reuters journalists are subject to an Editorial Handbook which requires fair presentation and disclosure of relevant interests.

NYSE and AMEX quotes delayed by at least 20 minutes. Nasdaq delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.